Skip to content

The PREMOD Trial: A Randomized Controlled Trial of Umbilical Cord Milking vs. Delayed Cord Clamping in Premature Infants

The PREMOD Trial: A Randomized Controlled Trial of Umbilical Cord Milking vs. Delayed Cord Clamping in Premature Infants

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01866982
Acronym
PREMOD
Enrollment
197
Registered
2013-06-03
Start date
2013-07-02
Completion date
2018-01-10
Last updated
2018-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intraventricular Hemorrhage

Keywords

umbilical cord milking, delayed cord clamping

Brief summary

Premature babies can be very sick and have bleeding in the brain. Giving babies more blood before cutting the umbilical cord by delayed cord clamping or umbilical cord milking has been shown to reduce the risk of bleeding in the brain. This may be related to improving perfusion to the brain. However, some studies suggest that delayed cord clamping may not increase hemoglobin or blood volume in babies delivered by cesarean section. Milking the umbilical cord may give more blood in babies delivered by Cesarean Section may improve perfusion and reduce bleeding in the brain.

Interventions

PROCEDUREUmbilical Cord Milking

Umbilical cord milked toward the neonate four times at a speed of 20cm/2seconds, prior to clamping and cutting umbilical cord. Procedure takes about 10-20 seconds.

PROCEDUREDelayed Cord Clamping

Performed by positioning the baby 20 cm below the placenta for 45-60 seconds prior to umbilical cord clamping and cutting.

Sponsors

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
CollaboratorNIH
Sharp HealthCare
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Singleton or multiples pregnancies in patients admitted for medically indicated delivery or in advanced spontaneous preterm labor with imminent delivery at 23 0/7 - 31 6/7 weeks gestation

Exclusion criteria

* Planned vaginal breech delivery * Major fetal abnormalities (defined as those that are lethal or require prenatal or postnatal surgery) * Fetal death in utero * Red cell isoimmunization * Patients who are incapable of informed consent (unconscious, severely ill, mentally handicapped), or are unwilling to undergo randomization * Placenta accreta or abruption

Design outcomes

Primary

MeasureTime frame
Superior Vena Cava Flow<12 hours of life

Secondary

MeasureTime frameDescription
Necrotizing enterocolitisup to 24 weeks after birth
Neonatal deathup to 24 weeks of life
Use of uterotonic agentsup to 1 hour after birth
Peak transcutaneous and/or serum bilirubin concentrationsup to 24 weeks after birt
Maternal hemoglobinwithin 48 hours after delivery
Intraventricular Hemorrhage detected on Head Ultrasoundup to 24 weeks after birth
Delivery Room Interventions10 minutes of life
Hemoglobin<1 hour
Neurodevelopmental impairment 18-36 months18-36 months
Severe intraventricular hemorrhage (grade 3 or 4)up to 24 weeks after birth
Phototherapyup to 24 weeks after birthRequirement and length of phototherapy
Ionotropic supportup to 24 weeks after birthRequirement and length of ionotropic support
Neonatal intensive care unit (NICU) length of stayup to 24 weeks after birth
Number of blood transfusions while in the neonatal intensive care unitup to 24 weeks after birth
Ventilator timeup to 24 weeks after birth
Apgar score <7 at 5 minutesat 5 minutes after birth
Umbilical cord pH < 7.0up to 30 minutes after birth
Blood pressure in first 2 hours of admission to neonatal intensive care unit2 hours after birth
Polycythemiaup to 24 hours of life

Other

MeasureTime frame
Cerebral Tissue OxygenationUp to 24 hours of life
Cardiac output by electric cardiometryup to 24 hours of life
Stroke volume by electric cardiometryUp to 24 hours of life
Vaginal Delivered infants (no difference in interventions)up to 24 weeks after birth
Days on Oxygenduring hospitalization

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 20, 2026